Table 1.
Patient data
| Beadchip | aCases | Controls | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | Male (%) | Female (%) | Age, mean (S.D.) | n | Male (%) | Female (%) | Age, mean (S.D.) | n | Age, mean (S.D.) | |
| Illumina 660 | 1193 | 55% | 45% | 66.7 (8.50) | 664 | 39% | 61% | 76.5 (8.50) | 1857 | 70.0 (9.73) |
| Illumina OEE | 294 | 51% | 49% | 65.6 (7.50) | 3009 | 36% | 64% | 75.0 (8.70) | 3303 | 74.0 (9.05) |
| Illumina GSA | 1030 | 56% | 44% | 65.7 (8.10) | 1226 | 40% | 60% | 73.0 (7.96) | 2256 | 69.8 (8.86) |
| Illumina GSA/OEE | 130 | 56% | 44% | 74.0 (17.9) | 632 | 50% | 50% | 84.0 (11.51) | 762 | 82.0 (13.7) |
| Illumina OEE, batch 2 | 132 | 52% | 48% | — | 53 | 45% | 55% | — | 185 | — |
| Total | 2779 | 55% | 45% | 66.5 (9.11) | 5584 | 40% | 60% | 75.8 (9.42) | 8363 | 72.8 (10.31) |
GSA global screening array, OEE Infinium Omni, SD standard deviation.
a125 PSP cases were not autopsy confirmed, age is years alive.